InVivo Therapeutics Initiates First Clinical Trial of Neuro-Spinal Scaffold

InVivo Therapeutics Holdings Corp. announced today that it has begun shipment of its innovative investigational device, a degradable polymer Neuro-Spinal Scaffold for spinal cord injury patients, for initiation of the company's first clinical trial.

http://ift.tt/1hIpOGl